Cargando…
Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
Dendritic cells (DCs) are well-established as major players in the regulation of immune responses. They either induce inflammatory or tolerogenic responses, depending on the DC-subtype and stimuli they receive from the local environment. This dual capacity of DCs has raised therapeutic interest for...
Autores principales: | Castenmiller, Charlotte, Keumatio-Doungtsop, Brigitte-Carole, van Ree, Ronald, de Jong, Esther C., van Kooyk, Yvette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933040/ https://www.ncbi.nlm.nih.gov/pubmed/33679806 http://dx.doi.org/10.3389/fimmu.2021.643240 |
Ejemplares similares
-
Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon
por: Ngwa, Che Henry, et al.
Publicado: (2021) -
Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
por: García-Vallejo, Juan J., et al.
Publicado: (2013) -
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
por: Nagy, Noémi Anna, et al.
Publicado: (2021) -
Human tolerogenic DC-10: perspectives for clinical applications
por: Amodio, Giada, et al.
Publicado: (2012) -
Soluble antigen arrays improve the efficacy and safety of peptide-based tolerogenic immunotherapy
por: Firdessa-Fite, Rebuma, et al.
Publicado: (2023)